Abcam has introduced a evaluation of strategic choices

Cambridge, England And Waltham, Mass, June 23, 2023 /PRNewswire/ — Abcam plc (“Abcam,” “Firm,” “Group”) (Nasdaq: ABCMA world chief within the provide of life science analysis tools introduced right now that its board of administrators has unanimously determined to start a course of to discover strategic choices for the corporate via in depth stakeholder engagement and listening. The whole course of begins instantly and evaluates a variety of choices to maximise shareholder worth, together with the sale of the corporate. As talked about earlier, Abcam has acquired strategic inquiries from a number of events over the previous few weeks.

The corporate commented: “Abcam is a novel asset that gives revolutionary merchandise and options to the worldwide life sciences group. Our board is totally aligned within the perception that the easiest way to maximise shareholder worth is to completely consider the corporate’s strategic choices, together with a possible sale of Abcam. It’s going to add worth to our shareholders.” And we observe a path that ensures profitable outcomes for our clients and staff.

The Board of Administrators engaged Lazard and Morgan Stanley as monetary advisors to help in evaluating strategic choices. Latham & Watkins was appointed as authorized counsel in reference to the evaluation course of.

There may be no assurance as to the end result or outcomes of this evaluation. Abcam doesn’t want to remark additional on this strategic evaluation course of and can make additional bulletins in accordance with subsequent disclosure obligations and relevant legal guidelines and rules.

About Abcam plc

As an innovator in reagents and instruments, Abcam’s mission is to serve life science researchers worldwide to speed up their mission. Offering instruments and scientific help to the analysis and medical communities, the corporate supplies extremely validated antibodies, assays and different analysis instruments to deal with essential targets in essential organic pathways.

A pioneer in knowledge sharing and e-commerce within the life sciences, Abcam’s ambition is to be essentially the most influential firm within the life sciences by serving to to develop international understanding of biology and illness pathogenesis, which in flip, results in new remedies and improved well being.

Abcam’s international buyer base of roughly 750,000 life science researchers makes use of Abcam’s antibodies, reagents, biomarkers and assays. By actively listening to and collaborating with these researchers, the corporate repeatedly expands its portfolio to satisfy their wants. Clear buyer critiques and knowledge sheets mixed with industry-leading validation initiatives give researchers confidence of their outcomes.

Within the yr Based in 1998 and headquartered in Cambridge, UK, the corporate serves purchasers in over 130 nations. Abcam’s American Depositary Shares (ADS) are traded on the Nasdaq Worldwide Choices Trade (NASDAQ: ABCM).

For extra data, please go to www.abcam.com Or www.abcamplc.com.

Ahead-looking statements

This commercial was printed in Incorporates forward-looking statements throughout the which means of the Personal Securities Litigation Modification Act of 1995. In some instances, you’ll be able to determine forward-looking statements by the next phrases: “could,” “might,” “might,” “could,” “could,” “ought to,” “anticipate,” “plan,” “anticipate,” “anticipate,” “anticipate,” “imagine,” “estimate,” “anticipate,” “potential,” “proceed,” “take into account,” “doable” or the negatives of such phrases or different synonyms, though not all forward-looking statements include such phrases. They don’t seem to be historic details, nor are they ensures of future efficiency. Any categorical or implied statements of non-historical details contained on this announcement could also be thought of forward-looking statements, together with with out limitation statements concerning the timing and scope of the Firm’s course of to discover strategic choices, the potential sale of Abcam, and the Abcam portfolio and Aspirations. These forward-looking statements will not be guarantees or ensures, however contain recognized and unknown dangers and uncertainties that would trigger precise outcomes to vary from these projected, together with, with out limitation: challenges in implementing our methods for income development in mild of aggressive challenges. Improvement of recent merchandise or enchancment of present merchandise, and the necessity to adapt to technological adjustments or to reply to the introduction of recent merchandise by rivals to stay aggressive; to discontinue or scale back our clients’ expenditures on analysis, growth, manufacturing or different scientific efforts; to be unable to efficiently determine or combine acquired companies or property, or to accumulate these we purchase; failure to completely understand the anticipated advantages of companies or property; The continued COVID-19 pandemic continues to influence our enterprise, together with variables, and the influence it would have on our operations and provide chains. the shortcoming to efficiently use, entry and preserve data programs and implement new programs to satisfy our altering wants; cybersecurity dangers and failure to keep up the confidentiality, integrity and availability of our laptop {hardware}, software program and Web purposes and associated gadgets and capabilities; incapability to efficiently handle our present and future development; any vital interruption in our operations; Our merchandise fail to satisfy relevant high quality requirements, specs and efficiency requirements; failure to guard and enhance our model and status; capability to reply to adversarial geopolitical or financial adjustments affecting life science funding; Failure to ship on transformational growth tasks; our dependence on administration and extremely expert personnel and our capability to draw and retain these extremely expert personnel; And as a overseas non-public issuer, we’re exempt from sure guidelines beneath U.S. securities legal guidelines and Nasdaq’s company governance guidelines and are permitted to supply much less data to the SEC than U.S. firms, which can restrict the knowledge obtainable to our U.S. shareholders. Depository Shares (“ADS”); and different essential components are mentioned beneath the caption “Threat Components” in Abcam’s Annual Report on Type 20-F for the yr ended December 31, 2022 (“Annual Report”) filed by the US Securities and Trade Fee (“SEC”). March 20, 2023Accessible on the SEC web site www.sec.gov, such components could also be up to date sometimes in Abcam’s subsequent filings with the SEC. Any forward-looking statements contained on this announcement communicate solely as of the date hereof and accordingly undue reliance shouldn’t be positioned on such statements. Abikam disclaims any obligation or obligation to replace or revise any forward-looking statements contained on this announcement, whether or not on account of new data, future occasions or in any other case, besides to the extent required by relevant legislation.

Emblem – https://mma.prnewswire.com/media/1670705/Abcam_Logo.jpg

Abcam plc
Tommy ThomasCPA
Vice President, Investor Relations
+1 617-577-4205
152 Grove Avenue, Constructing 1100
Waltham, MA 02453

Media inquiries

America: Joel Frank
+1 212-355-4449
abcam-j[email protected]

UK and Europe: FTI
+44 (0) 20-3727-1000
[email protected]Com

Supply Abcam PLC